RH
Rinkalben Hirenkumar Dhameliya
About Rinkalben Hirenkumar Dhameliya
Data last updated:
Rinkalben Hirenkumar Dhameliya is a Director at Balextra Lifescience Private Limited (since 2023). The company operates in Chemicals. Balextra Lifescience Private Limited reported revenue of ₹68.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Balextra Lifescience Private Limited U24290GJ2023PTC138491 | Director | 18 Jan 2023 | 2023 | ₹68.3 Lakh (FY 2025) | Active |
Board colleagues of Rinkalben Hirenkumar Dhameliya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jyoti Vipulkumar Moradiya | 09862311 | Balextra Lifescience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rinkalben Hirenkumar Dhameliya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rinkalben Hirenkumar Dhameliya
Rinkalben Hirenkumar Dhameliya currently holds 1 directorship: Balextra Lifescience Private Limited (Director, since 18 Jan 2023, revenue ₹68.3 Lakh (FY 2025)).
Rinkalben Hirenkumar Dhameliya was first appointed on 18 Jan 2023 as Director at Balextra Lifescience Private Limited.
The current boards of Rinkalben Hirenkumar Dhameliya's companies include Jyoti Vipulkumar Moradiya (Balextra Lifescience Private Limited).